Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro, and in vivo study

References

• Allahou LW, Madani SY, Seifalian A. Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. Int J Biomater. 2021;2021:1–16.
   Web of Science ®Google Scholar
• Daraee H, Etemadi A, Kouhi M, et al. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44(1):381–391.
   PubMed Web of Science ®Google Scholar
• Bhardwaj P, Bhatia E, Sharma S, et al. Advancements in prophylactic and therapeutic nanovaccines. Acta Biomater. 2020;108:1–21.
   PubMed Web of Science ®Google Scholar
• Barenholz YC. Doxil®—the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–134.
   PubMed Web of Science ®Google Scholar
• Rios-Doria J, Durham N, Wetzel L, et al. Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models. Neoplasia. 2015;17(8):661–670.
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly (ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta (BBA) Biomembr. 1994;1195(1):11–20.
   PubMed Web of Science ®Google Scholar
• Maruyama K. PEG-immunoliposome. Biosci Rep. 2002;22(2):251–266.
   PubMed Web of Science ®Google Scholar
• Ishida T, Harada M, Wang XY, et al. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release. 2005;105(3):305–317.
   PubMed Web of Science ®Google Scholar
• Basavaraj S, Betageri GV. Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges. Acta Pharm Sin B. 2014;4(1):3–17.
   PubMed Web of Science ®Google Scholar
• Vllasaliu D, Fowler R, Stolnik S. PEGylated nanomedicines: recent progress and remaining concerns. Expert Opin Drug Deliv. 2014;11(1):139–154.
   PubMed Web of Science ®Google Scholar
• Ding Y, Sun D, Wang G-L, et al. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-Fdrug delivery. Int J Nanomedicine. 2015;10:6199.
   PubMed Web of Science ®Google Scholar
• Mashreghi M, Faal Maleki M, Karimi M, et al. Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide. J Drug Target. 2021;29(6):617–630.
   PubMed Web of Science ®Google Scholar
• Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009;15(17):5323–5337.
   PubMed Web of Science ®Google Scholar
• Pinto R, Carvalho AS, Conze T, et al. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. J Cell Mol Med. 2012;16(7):1474–1484.
   PubMed Web of Science ®Google Scholar
• Julien S, Videira PA, Delannoy P. Sialyl-tn in cancer:(how) did we miss the target? Biomolecules. 2012;2(4):435–466.
   PubMedGoogle Scholar
• Beckwith DM, Cudic M. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design. Seminars in immunology. 2020;47:101389.
   PubMed Web of Science ®Google Scholar
• Horm TM, Schroeder JA. MUC1 and metastatic cancer: expression, function and therapeutic targeting. Cell Adh Migr. 2013;7(2):187–198.
   PubMed Web of Science ®Google Scholar
• Asoodeh A, Zardini HZ, Chamani J. Identification and characterization of two novel antimicrobial peptides, temporin‐Ra and temporin‐Rb, from skin secretions of the marsh frog (Rana ridibunda). J Pept Sci. 2012;18(1):10–16.
   PubMed Web of Science ®Google Scholar
• Romero SM, Cardillo AB, Martínez Ceron MC, et al. Temporins: an approach of potential pharmaceutic candidates. Surg Infect (Larchmt). 2020;21(4):10–16.
   Web of Science ®Google Scholar
• Asoodeh A, Haghighi L, Chamani J, et al. Potential angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate: biochemical characterization and molecular docking study. J Cereal Sci. 2014;60(1):92–98.
   Web of Science ®Google Scholar
• Rozek T, Bowie JH, Wallace JC, et al. The antibiotic and anticancer active aurein peptides from the Australian bell frogs Litoria aurea and Litoria raniformis. Part 2. Sequence determination using electrospray mass spectrometry. Rapid Commun Mass Spectrom. 2000;14(21):2002–2011.
   PubMed Web of Science ®Google Scholar
• Asperger A, Marx K, Albers C, et al. Low abundant N-linked glycosylation in hen egg white lysozyme is localized at nonconsensus sites. J Proteome Res. 2015;14(6):2633–2641.
   PubMed Web of Science ®Google Scholar
• Thévenet P, Shen Y, Maupetit J, et al. PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res. 2012;40(W1):W288–W93.
   PubMed Web of Science ®Google Scholar
• Guex N, Peitsch MC. Swiss‐MODEL and the Swiss‐Pdb Viewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714–2723.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Rullmann JAC, MacArthur MW, et al. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR. 1996;8(4):2714–2723.
   Web of Science ®Google Scholar
• Andrusier N, Nussinov R, Wolfson HJ. FireDock: fast interaction refinement in molecular docking. proteins: structure, function, and bioinformatics. Proteins. 2007;69(1):139–159.
   PubMed Web of Science ®Google Scholar
• DeLano WL. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA, USA, 2002.
   Google Scholar
• Laskowski RA, Swindells MB. LigPlot+: multiple ligand–protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778–2786. ACS Publications.
   PubMed Web of Science ®Google Scholar
• Hess B, Kutzner C, van der Spoel D, et al. GROMACS 4:  algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4(3):435–447.
   PubMed Web of Science ®Google Scholar
• Mesh Ewald P, York D, Pedersen L. An N⋅ log (N) an method for Ewald sums in large systems. J Chem Phys. 1993;98(12):10089–10092.
   Web of Science ®Google Scholar
• Ryckaert J-P, Ciccotti G, Berendsen HJ. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23(3):327–341.
   Web of Science ®Google Scholar
• Hess B, Bekker H, Berendsen HJ, et al. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18(12):10089–10092.
   Web of Science ®Google Scholar
• Fischer MJE (2010). Amine Coupling Through EDC/NHS: A Practical Approach. In: Mol N Fischer M (editors) Surface Plasmon Resonance. Methods in Molecular Biology, Vol. 627. Humana Press.
   Google Scholar
• Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234(3):466–468.
   PubMed Web of Science ®Google Scholar
• Farzaneh H, Nik ME, Mashreghi M, et al. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy. Int J Pharm. 2018;551(1–2):1463–1472.
   Google Scholar
• Moreira JN, Ishida T, Gaspar R, et al. Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm Res. 2002;19(3):265–269.
   PubMed Web of Science ®Google Scholar
• Shahraki N, Mehrabian A, Amiri-Darban S, et al. Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma. Colloids Surf B Biointerfaces. 2021;200:111589.
   PubMed Web of Science ®Google Scholar
• Haftcheshmeh SM, Jaafari MR, Mashreghi M, et al. Liposomal doxorubicin targeting mitochondria: a novel formulation to enhance anti-tumor effects of Doxil® in vitro and in vivo. J Drug Delivery Sci Technol. 2021;62:102351.
   Web of Science ®Google Scholar
• Haghiralsadat F, Amoabediny G, Helder MN, et al. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Artif Cells Nanomed Biotechnol. 2018;46(1):169–177.
   PubMed Web of Science ®Google Scholar
• Hamedinasab H, Rezayan AH, Mellat M, et al. Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine. Int J Biol Macromol. 2020;156(156):1455–1463.
   PubMedGoogle Scholar
• Arabi L, Badiee A, Mosaffa F, et al. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. J Control Release. 2015;220:275–286.
   PubMed Web of Science ®Google Scholar
• Huang Z, Jaafari MR, Szoka JFC. Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery. Angew Chem. 2009;121(23):4210–4213.
   Google Scholar
• Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1(4):274–278.
   PubMedGoogle Scholar
• Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 1963;7(1):95–99.
   PubMed Web of Science ®Google Scholar
• Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99(6):1129–1143.
   PubMed Web of Science ®Google Scholar
• Zhiping Z, Jianmin X, Xubing S, et al. Calculation of the mean-square radius of gyration for polymer chains with side-groups. Eur Polym J. 1992;28(11):1339–1343.
   Web of Science ®Google Scholar
• Razzaq S, Rauf A, Raza A, et al. A multifunctional polymeric micelle for targeted delivery of paclitaxel by the inhibition of the P-Glycoprotein transporters. Nanomaterials. 2021;11(11):2858.
   Web of Science ®Google Scholar
• Arshad R, Tabish TA, Kiani MH, et al. A hyaluronic acid functionalized self-nano-emulsifying drug delivery system (SNEDDS) for enhancement in ciprofloxacin targeted delivery against intracellular infection. Nanomaterials. 2021;11(5):1086.
   Web of Science ®Google Scholar
• Rahdar A, Taboada P, Hajinezhad MR, et al. Effect of tocopherol on the properties of Pluronic F127 microemulsions: physico-chemical characterization and in vivo toxicity. J Mol Liq. 2019;277:624–630.
   Web of Science ®Google Scholar
• Haddadzadegan S, Dorkoosh F, Bernkop-Schnurch A. Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022;182:114097.
   PubMed Web of Science ®Google Scholar
• Thapa RK, Diep DB, Tønnesen HH. Topical antimicrobial peptide formulations for wound healing: current developments and future prospects. Acta Biomater. 2020;103:52–67.
   PubMed Web of Science ®Google Scholar
• Gupta M, Sharma R, Kumar A. Docking techniques in pharmacology: how much promising? Comput Biol Chem. 2018;76:210–217.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Kidachi Y, Kamiie K, et al. Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex. Bioinformation. 2012;8(23):1147.
   PubMedGoogle Scholar
• Woods AS. The mighty arginine, the stable quaternary amines, the powerful aromatics, and the aggressive phosphate: their role in the noncovalent minuet. J Proteome Res. 2004;3(3):478–484.
   PubMed Web of Science ®Google Scholar
• Tunaru S, Lättig J, Kero J, et al. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol Pharmacol. 2005;68(5):1271–1280.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhao C, Liu P, et al. Facile construction of dual-targeting delivery system by using lipid capped polymer nanoparticles for anti-glioma therapy. RSC Adv. 2018;8(1):444–453.
   Web of Science ®Google Scholar
• Wang F, Chen L, Zhang R, et al. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. J Control Release. 2014;196:222–233.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao Y, Jiang Y, et al. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system. Sci Rep. 2015;5(1):1–15.
   Google Scholar
• Shokri A, Akhtari J, Keighobadi M, et al. Promising antileishmanial effectiveness of doxorubicin and Doxil against Leishmania major: an in vitro assay. Asian Pac J Trop Med. 2017;10(6):544–548.
   PubMed Web of Science ®Google Scholar
• Waterhouse DN, Tardi PG, Mayer LD, et al. A comparison of liposomal formulations of doxorubicin with drug administered in free form. Drug Saf. 2001;24(12):903–920.
   PubMedGoogle Scholar
• Tsukioka Y, Matsumura Y, Hamaguchi T, et al. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil). Jpn J Cancer Res. 2002;93(10):1145–1153.
   PubMedGoogle Scholar
• Movafegh B, Jalal R, Mohammadi Z, et al. Poly-L-arginine: enhancing cytotoxicity and cellular uptake of doxorubicin and necrotic cell death. Anti-Cancer Agents Med Chem. 2018;18(10):1448–1456.
   PubMed Web of Science ®Google Scholar
• Fang J-Y, Lee W-R, Shen S-C, et al. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci. 2006;42(2):101–109.
   PubMed Web of Science ®Google Scholar
• Gabizon AA. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 1992 Feb 15;52(4):891–896.
   PubMed Web of Science ®Google Scholar
• Nagayasu A, Uchiyama K, Nishida T, et al. Is control of distribution of liposomes between tumors and bone marrow possible? Biochim Biophys Acta (BBA) Biomembr. 1996;1278(1):29–34.
   PubMed Web of Science ®Google Scholar
• Darban SA, Badiee A, Jaafari MR. PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells. Nanomedicine. 2017;12(12):1475–1490.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Patel H. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system–the concept of tissue specificity. Adv Drug Deliv Rev. 1998;32(1–2):45–60.
   PubMed Web of Science ®Google Scholar
• Amin M, Mansourian M, Koning GA, et al. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region. J Control Release. 2015;220:308–315.
   PubMed Web of Science ®Google Scholar
• Rui S, Bradley S, Alexander E, et al. Liposome technologies towards colorectal cancer therapeutics. Acta Biomater. 2021;127:24–40. PubMed PMID: SANG202124.
   PubMed Web of Science ®Google Scholar
• Ligtenberg MJ, Kruijshaar L, Buijs F, et al. Cell-associated episialin is a complex containing two proteins derived from a common precursor. J Biol Chem. 1992;267(9):6171–6177. Epub 1992/03/25. PubMed PMID: 1556125.
   PubMed Web of Science ®Google Scholar
• Morelle W, Stechly L, André S, et al. Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking. Biol Chem. 2009;390(7):529–544. Epub 2009/05/12.PubMed PMID: 19426135
   PubMed Web of Science ®Google Scholar
• Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
   PubMed Web of Science ®Google Scholar
• Oude Blenke E, Mastrobattista E, Schiffelers RM. Strategies for triggered drug release from tumor targeted liposomes. Expert Opin Drug Deliv. 2013;10(10):1399–1410.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Gupta V, Zern BJ, et al. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS nano. 2013;7(12):11129–11137.
   PubMed Web of Science ®Google Scholar
• Yue CS, Ducharme MP. Empirical models, mechanistic models, statistical moments, and noncompartmental analysis. In: Shargel L, Yu ABC, editors. Applied Biopharmaceutics & Pharmacokinetics, 7e, chapter 25. New York NY: McGraw-Hill Education; 2016.
   Google Scholar
• Mashreghi M, Zamani P, Moosavian SA, et al. Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: in vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma. Nanoscale Res Lett. 2020;15(1):1–13.
   PubMed Web of Science ®Google Scholar